TerminatedPhase 1NCT00866086

Comfort Level of Two Abdominal Compression Methods Used to Hold Patients Still While Undergoing Stereotactic Body Radiation Therapy for Lung Tumors

RATIONALE: Stereotactic body radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. Abdominal compression methods that hold the body and the tumor from moving during treatment may permit radiation therapy to kill more tumor cells. This study is looking at the comfort level of two abdominal compression methods in patients with lung tumors undergoing stereotactic body radiation therapy. PURPOSE: This phase I trial is studying the comfort level of two abdominal compression methods used to hold patients still while undergoing stereotactic body radiation therapy for lung tumors.

Checked against the public recordLast updated Aug 20, 2020 · Source: ClinicalTrials.gov

StatusTerminated
PhasePhase 1
U.S. locations1
SponsorUniversity of Texas Southwestern Medical Center
01
Study overview

What this study is about

Purpose
Diagnostic
Study type
Interventional
Phase
Phase 1
Sponsor
University of Texas Southwestern Medical Center
Interventions being studied
Other: questionnaire administration; Procedure: computed tomography; Radiation: radiation therapy treatment planning/simulation
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
03
Public criteria

Who may be able to participate

DISEASE CHARACTERISTICS: * All lung patients from the University of Texas Southwestern Medical Center, Parkland Health and Hospital System, and Richardson Regional Cancer Center scheduled to receive stereotactic body radiotherapy simulation * Must have initial pre-compression lung tumor motions with respiration \> 1 cm PATIENT CHARACTERISTICS: * Negative pregnancy test PRIOR CONCURRENT THERAPY: * Concurrent participation in other protocols allowed

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - DallasDallas, Texas

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 20, 2020. Always confirm current availability with the study team.

View original record ↗